RayzeBio - Ownership and Business Overview

Life ScienceCompany

RayzeBio Ownership

Who owns RayzeBio?

RayzeBio is owned by Bristol-Myers Squibb. It was acquired on December 26, 2023.

RayzeBio Business Overview

Where is RayzeBio headquartered?

RayzeBio is headquartered in San Diego, California.

What sector is RayzeBio in?

RayzeBio is a life science company.

Life Science M&A Summary in 2023

Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2023. The largest life science acquisition in 2023 was Seagen - which was acquired by Pfizer for $43.0B.

Join Mergr to view all 201 acquisitions of life science companies in 2023, including 25 acquisitions by private equity firms, and 176 by strategics.

RayzeBio

RayzeBio, Inc.

5505 Morehouse Drive, Suite 300,
San Diego, California 92121
United States,
www.rayzebio.com

RayzeBio is building a radiopharmaceutical therapeutics (RPT) company to treat various cancers, with its lead program in a Phase 3 clinical trial. The company has created a pipeline of multiple drug candidates in therapeutic areas with significant market opportunities. Much like antibody-drug conjugates emerged as a new and transformative treatment modality in certain cancers, it sees an opportunity for innovative radiopharmaceutical therapeutics to follow a similar path. RayzeBio is based in San Diego, California.


 Subscribe to unlock this and 207,390
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.